TrialInflammatory bowel diseases2016

Assessing Colonic Exposure, Safety, and Clinical Activity of SRT2104, a Novel Oral SIRT1 Activator, in Patients with Mild to Moderate Ulcerative Colitis.

Bruce E Sands et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.